A detailed history of Bayesian Capital Management, LP transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Bayesian Capital Management, LP holds 2,269 shares of JAZZ stock, worth $278,610. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,269
Holding current value
$278,610
% of portfolio
0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.57 - $116.37 $228,193 - $264,043
2,269 New
2,269 $252,000
Q3 2023

Nov 14, 2023

BUY
$122.0 - $145.31 $366,000 - $435,930
3,000 Added 161.46%
4,858 $628,000
Q2 2023

Aug 14, 2023

SELL
$122.5 - $147.16 $983,552 - $1.18 Million
-8,029 Reduced 81.21%
1,858 $230,000
Q1 2023

May 15, 2023

BUY
$133.98 - $160.47 $93,652 - $112,168
699 Added 7.61%
9,887 $1.45 Million
Q4 2022

Feb 14, 2023

BUY
$129.72 - $159.85 $466,992 - $575,460
3,600 Added 64.42%
9,188 $1.46 Million
Q3 2022

Nov 14, 2022

BUY
$126.59 - $161.18 $707,384 - $900,673
5,588 New
5,588 $745,000
Q4 2021

Feb 14, 2022

SELL
$119.87 - $145.67 $586,044 - $712,180
-4,889 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$128.64 - $184.79 $425,927 - $611,839
-3,311 Reduced 40.38%
4,889 $637,000
Q2 2021

Aug 13, 2021

SELL
$160.2 - $186.42 $177,982 - $207,112
-1,111 Reduced 11.93%
8,200 $1.46 Million
Q1 2021

May 14, 2021

BUY
$150.19 - $173.5 $1.4 Million - $1.62 Million
9,311 New
9,311 $1.53 Million
Q3 2019

Nov 13, 2019

SELL
$125.18 - $143.24 $2 Million - $2.29 Million
-16,007 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$125.55 - $144.48 $2.01 Million - $2.31 Million
16,007 New
16,007 $2.28 Million
Q3 2018

Nov 14, 2018

SELL
$161.01 - $180.57 $209,313 - $234,741
-1,300 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$146.33 - $183.18 $190,229 - $238,134
1,300 New
1,300 $224,000
Q1 2018

May 15, 2018

SELL
$135.59 - $157.16 $252,468 - $292,631
-1,862 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$131.06 - $150.39 $244,033 - $280,026
1,862
1,862 $251,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.7B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.